跳至主要内容
临床试验/NL-OMON37522
NL-OMON37522尚未招募不适用

Implementation of a Transcutaneous Bilirubinometer among Newborns: A Randomized Controlled Trial - Transcutaneous Bilirubinometer

Isala Klinieken0 个研究点目标入组 550 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
550

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 11(—)

入选标准

  • All newborns at the pediatric- and maternity-ward with visible jaundice.
  • Gestational age of 32 weeks or more.
  • Older than 24 hours.
  • younger than 8 days.

排除标准

  • Neonatal jaundice within 24 hours or after 8 days
  • Hemolysis present based on maternal history (for example irregular erythrocyte antibodies)
  • Bilirubin encephalopathy
  • Newborns during/after phototherapy
  • Large congenital anomaly at forehead/sternum
  • Serum bilirubin-value is already known before admission to the pediatric ward;those newborns are to be admitted because the serum bilirubin-level has reached the phototherapy or exchange transfusion limit.

研究者

发起方
Isala Klinieken

相似试验

Implementation of a Transcutaneous Bilirubinometer... | 临床试验